Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Ultragenyx Pharmaceutical Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
McKesson Corporation July 31, 202499.4%
-
Ultragenyx Pharmaceutical Inc. June 18, 202489.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 2026 | Ultragenyx Pharmaceutical Inc. | Grant or award | +7,751 | — | — |
| May 15, 2025 | Ultragenyx Pharmaceutical Inc. | Grant or award | +5,740 | — | — |
| Jun 18, 2024 | Ultragenyx Pharmaceutical Inc. | Grant or award | +5,345 | — | — |
| Jun 7, 2023 | Ultragenyx Pharmaceutical Inc. | Grant or award | +3,860 | — | — |
Questions about Deborah Dunsire
What boards is Deborah Dunsire on?
Deborah Dunsire sits on the boards of McKesson Corporation and Ultragenyx Pharmaceutical Inc.
How long has Deborah Dunsire served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.